Form 4: Nuvalent CDO Sells Shares After Option Exercise

Nuvalent's Chief Development Officer, Darlene Noci, exercised stock options and subsequently sold 4,000 shares of Class A Common Stock on September 29, 2025, under a pre-arranged 10b5-1 trading plan.

Summary

• Darlene Noci, Nuvalent, Inc.'s Chief Development Officer, executed transactions involving the company's Class A Common Stock on September 29, 2025.
• The transactions included the acquisition of 4,000 shares through the exercise of stock options at a price of $27.85 per share.
• Concurrently, 4,000 shares were disposed of through multiple sales at weighted average prices ranging from $81.39 to $84.92 per share.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted by Ms. Noci on November 18, 2024.
• Following these transactions, Ms. Noci beneficially owns 48,034 shares of Class A Common Stock directly and 126,329 stock options.
• The stock options exercised were part of a grant that vests over four years following January 6, 2023, in equal monthly installments, subject to continued service.

Sentiment

Score: 5

Explanation: The sentiment is neutral as this is a routine, pre-planned insider transaction under a 10b5-1 plan, which typically does not reflect new information about the company's performance or prospects.

Positives

• The transactions were executed under a pre-arranged Rule 10b5-1 trading plan, indicating that the sales were not based on new, non-public information.
• The Chief Development Officer continues to hold a significant number of shares (48,034) and stock options (126,329) in Nuvalent, Inc., demonstrating ongoing alignment with shareholder interests.

Negatives

• An officer selling shares, even under a pre-arranged plan, can sometimes be perceived negatively by some market participants, although the 10b5-1 plan mitigates concerns about opportunistic trading.

Risks

• Potential for negative market perception regarding insider sales, even when conducted under a Rule 10b5-1 plan, which could lead to short-term stock price volatility.

Future Outlook

This Form 4 filing reports past insider transactions and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This filing is a routine insider transaction report and does not provide specific industry context or competitive analysis. Such transactions are common across all industries for executives managing their equity compensation.

Stakeholder Impact

• Shareholders: The transaction is a routine insider sale under a pre-arranged plan, which generally has minimal direct impact on shareholders. The officer retains significant equity holdings.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

The reported transactions are routine insider sales executed under a pre-arranged 10b5-1 trading plan, which typically do not indicate a change in the company's fundamental outlook or warrant a shift in investment strategy. The officer continues to hold a significant number of shares and options, suggesting ongoing alignment with the company's long-term success.

Keywords

Nuvalent, NUVL, Form 4, Insider Trading, Stock Options, Share Sale, Darlene Noci, 10b5-1 Plan